Cardiovascular Radiology: Page 233

Neoprobe, Estech expand distribution deal
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has expanded its distribution agreement with Estech of San Ramon, CA.
September 10, 2006
Kodak named distributor for Novadaq’s Spy
By AuntMinnie.com staff writers
Eastman Kodak Health Group of Rochester, NY, has signed an agreement with Novadaq Technologies to be the Toronto firm's sole European and emerging markets distributor of the Spy intraoperative imaging system for cardiac surgery.
September 10, 2006
Technology broadens scope of cardiac MR
By Eric Barnes
From perfusion imaging to infarct detection and guided intervention, cardiac MRI (CMRI) is gaining utility and fans in the academic world and beyond. The options are poised to expand rapidly in the coming years thanks to better coil designs, higher field strengths in scanners, and specialized contrast agents, to name a few of the forces shaping CMR's future.
September 10, 2006
2006 09 01 16 37 22 706
Allscripts inks Memorial Healthcare deal
By AuntMinnie.com staff writers
Healthcare information technology developer Allscripts reported that Memorial Healthcare, a 148-bed hospital in Ossowo, MI, has selected its HealthMatics Office integrated electronic medical record (EMR) and practice management system (PMS).
September 6, 2006
Philips notches 1,000th CardioMD install, debuts Xcelera 2.1
By AuntMinnie.com staff writers
Philips Medical Systems is displaying the latest iteration of its integrated cardiovascular information application, Xcelera 2.1, at the American Society of Nuclear Cardiology meeting in Montreal this week.
September 6, 2006
Positron partners with MIMvista
By AuntMinnie.com staff writers
PET developer Positron of Houston has entered into a partnership with MIMvista, a Cleveland-based developer of advanced visualization software for nuclear medicine.
September 6, 2006
Cordis gets CE Mark for Cypher Select
By AuntMinnie.com staff writers
Johnson & Johnson subsidiary Cordis Endovascular has received the European CE Mark for its Cypher Select sirolimus-eluting stent.
September 5, 2006
More data will be key to CTA reimbursement
By Wayne Forrest
To reach appropriate reimbursement levels, Dr. Geoffrey Rubin, professor of radiology at Stanford University in California, said several criteria must first be met. In his presentation at Stanford's 2006 International Symposium on Multidetector-Row CT in San Francisco, Rubin outlined several technology assessment steps that Blue Cross and Blue Shield uses on a national level to determine the value of technology and its benefit to healthcare.
September 5, 2006
Multislice CT almost as good as IVUS in acute coronary syndromes
By Edward Susman
BARCELONA - In the early stage of acute coronary syndrome, 16-slice multidetector-row CT can locate the culprit lesion, according to a presentation this week at the European Society of Cardiology's World Congress of Cardiology. Researchers from University Hospital in Bordeaux, France compared 16-slice CT to 40-MHz catheter-based intravascular ultrasound (IVUS).
September 5, 2006
MRI market to top $4 billion by 2010
By AuntMinnie.com staff writers
Increases in the use of interventional MRI in brain surgery will drive the worldwide MRI market to $4 billion in anticipated revenues by 2010, according to research firm Kalorama Information.
September 4, 2006
Stress MPI with Tc-99m SPECT identifies high-risk obese patients
By Jonathan S. Batchelor
Identifying an accurate method for risk stratification of obese patients with coronary artery disease is critically important to limit invasive procedures for high-risk patients, according to researchers from the U.S. and the Netherlands. They found that stress myocardial perfusion imaging (MPI) with Tc-99m tetrofosmin is a valuable, noninvasive tool for predicting mortality and cardiac events in obese patients.
August 31, 2006
Boston Scientific reaches halfway point in drug-eluting stent trial
By AuntMinnie.com staff writers
Interventional device developer Boston Scientific of Natick, MA, reported that enrollment has exceeded 13,000 patients in the Taxus Olympia registry, designed to evaluate the safety and performance of its second-generation drug-eluting coronary stent, the Taxus Liberté.
August 30, 2006
Previous Page
Page 233 of 326
Next Page